Prostate-specific antigen (PSA) is a protein produced by both normal and cancerous cells in the prostate gland. It is primarily measured through a blood test, where normal levels are typically found ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that its Decipher Prostate Genomic Classifier is the only gene ...

An Italian oncologic psychologist warns these patients: “A prostatectomy doesn’t cure anxiety.” Emotional distress can be so ...

An article about the importance of PSA testing for early detection and treatment of prostate cancer ...

After decades of overtreatment for low-risk prostate cancer and inadequate management of its more aggressive forms, patients are now more likely to receive medical care matched to level of risk, ...

Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study We conducted a nested case-control study among men age 40 to 59 years who gave blood ...

When prostate cancer strikes, one question is paramount: Is it aggressive and requiring immediate treatment, or slow-growing and worthy of monitoring only? Right now, an invasive biopsy is the only ...

Researchers say they've developed a urine test that could answer whether prostate cancer is aggressive and requiring immediate treatment, or slow-growing and worthy ...

Los Angeles, Calif. – Testosterone therapy does not cause adverse effects on the prostate in older men with hypogonadism, commonly known as low testosterone or low T, according to a clinical trial ...